Dementia of the Alzheimer Type
Open Access
- 14 May 2008
- journal article
- review article
- Published by Oxford University Press (OUP) in Epidemiologic Reviews
- Vol. 30 (1) , 15-34
Abstract
Dementia of the Alzheimer type is a progressive, fatal neurodegenerative condition characterized by deterioration in cognition and memory, progressive impairment in the ability to carry out activities of daily living, and a number of neuropsychiatric symptoms. This narrative review summarizes the literature regarding descriptive epidemiology, clinical course, and characteristic neuropathological changes of dementia of the Alzheimer type. Although there are no definitive imaging or laboratory tests, except for brain biopsy, for diagnosis, brief screening instruments and neuropsychiatric test batteries used to assess the disease are discussed. Insufficient evidence exists for the use of biomarkers in clinical practice for diagnosis or disease management, but promising discoveries are summarized. Optimal treatment requires both nonpharmacological and pharmacological interventions, yet none have been shown to modify the disease's clinical course. This review describes the current available options and summarizes promising new avenues for treatment. Issues related to the care of persons with dementia of the Alzheimer type, including caregiver burden, long-term care, and the proliferation of dementia special care units, are discussed. Although advances have been made, more research is needed to address the gaps in our understanding of the disease.Keywords
This publication has 306 references indexed in Scilit:
- Point and 5‐year period prevalence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2007
- Cognitive effects of atypical antipsychotics in patients with Alzheimer's disease and comorbid psychiatric or behavioral problems: A retrospective studyClinical Therapeutics, 2006
- Global prevalence of dementia: a Delphi consensus studyThe Lancet, 2005
- Memantine Treatment in Patients With Moderate to Severe Alzheimer Disease Already Receiving DonepezilJAMA, 2004
- Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐BAnnals of Neurology, 2004
- The persistence of neuropsychiatric symptoms in dementia: the Cache County StudyInternational Journal of Geriatric Psychiatry, 2004
- Symptômes comportementaux et psychologiques dans la maladied' Alzheimer : résultats de l'étude REAL.FRLa Revue de Médecine Interne, 2003
- Increased plasma apolipoprotein E (apoE) levels in Alzheimer's diseaseNeuroscience Letters, 1997
- The progression of medicine. From physician paternalism to patient autonomy to bureaucratic parsimonyArchives of internal medicine (1960), 1985
- Neurotransmitter-related enzymes in senile dementia of the alzheimer typeBrain Research, 1979